ArticleExpert opinion on pharmacotherapy2008

New horizons for zoledronic acid: results of the HORIZON trials in postmenopausal women with osteoporosis and after hip fracture.

Sheila A DoggrellPubMed ↗Publisher ↗

No numbers read from the abstract.